Clinical experience with non-nucleoside reverse transcriptase inhibitors: L697,661 and nevirapine

被引：0
|
作者：
Kilby, JM
Saag, MS
机构：
来源：
ANTIVIRAL CHEMOTHERAPY 4: NEW DIRECTIONS FOR CLINICAL APPLICATION AND RESEARCH | 1996年 / 394卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：291 / 298
页数：8
相关论文
共 50 条
  • [41] Optimization of 5-Aryloxyimidazole Non-Nucleoside Reverse Transcriptase Inhibitors
    Jones, Lyn H.
    Allan, Gill
    Corbau, Romuald
    Hay, Duncan
    Middleton, Donald S.
    Mowbray, Charles E.
    Newman, Sandra D.
    Perros, Manos
    Randall, Amy
    Vuong, Hannah
    Webster, Rob
    Westby, Mike
    Williams, David
    CHEMMEDCHEM, 2008, 3 (11) : 1756 - 1762
  • [42] Design and Synthesis of Conformationally Constrained Inhibitors of Non-Nucleoside Reverse Transcriptase
    Gomez, Robert
    Jolly, Samson J.
    Williams, Theresa
    Vacca, Joseph P.
    Torrent, Maricel
    McGaughey, Georgia
    Lai, Ming-Tain
    Felock, Peter
    Munshi, Vandna
    DiStefano, Daniel
    Flynn, Jessica
    Miller, Mike
    Yan, Youwei
    Reid, John
    Sanchez, Rosa
    Liang, Yuexia
    Paton, Brenda
    Wan, Bang-Lin
    Anthony, Neville
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (22) : 7920 - 7933
  • [43] Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1
    Moreno, S
    Casado, JL
    Pérez-Elias, MI
    Dronda, F
    Antela, A
    Moreno, A
    Gutiérrez, C
    AIDS, 2003, 17 (09) : 1413 - 1414
  • [44] Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
    Vanangamudi, Murugesan
    Palaniappan, Senthilkumar
    Kathiravan, Muthu Kumaradoss
    Namasivayam, Vigneshwaran
    VIRUSES-BASEL, 2023, 15 (10):
  • [45] Advances in the development of pyridinone derivatives as non-nucleoside reverse transcriptase inhibitors
    Vite-Caritino, Hugo
    Mendez-Lucio, Oscar
    Reyes, Hector
    Cabrera, Alberto
    Chavez, Daniel
    Medina-Franco, Jose L.
    RSC ADVANCES, 2016, 6 (03): : 2119 - 2130
  • [46] Development of practical syntheses of potent non-nucleoside reverse transcriptase inhibitors
    Kuethe, Jeffrey T.
    Zhong, Yong-Li
    Alam, Mahbub
    Alorati, Anthony D.
    Beutner, Gregory L.
    Cai, Dongwei
    Fleitz, Fred J.
    Gibb, Andrew D.
    Kassim, Amude
    Linn, Kathleen
    Mancheno, Danny
    Marcune, Benjamin
    Pye, Philip J.
    Scott, Jeremy P.
    Tellers, David M.
    Xiang, Bangping
    Yasuda, Nobuyoshi
    Yin, Jingjun
    Davies, Ian W.
    TETRAHEDRON, 2009, 65 (26) : 5013 - 5023
  • [47] Non-nucleoside reverse transcriptase inhibitors (NNRTIs): Past, present, and future
    De Clercq, E
    CHEMISTRY & BIODIVERSITY, 2004, 1 (01) : 44 - 64
  • [48] The emerging roles of non-nucleoside reverse transcriptase inhibitors in antiretroviral therapy
    Moyle, G
    DRUGS, 2001, 61 (01) : 19 - 26
  • [49] Susceptibility of recombinant porcine endogenous retrovirus reverse transcriptase to nucleoside and non-nucleoside inhibitors
    M. Wilhelm
    J. A. Fishman
    R. Pontikis
    A.-M. Aubertin
    F. X. Wilhelm
    Cellular and Molecular Life Sciences CMLS, 2002, 59 : 2184 - 2190
  • [50] Susceptibility of recombinant porcine endogenous retrovirus reverse transcriptase to nucleoside and non-nucleoside inhibitors
    Wilhelm, M
    Fishman, JA
    Pontikis, R
    Aubertin, AM
    Wilhelm, FX
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (12) : 2184 - 2190
12345